OBJECTIVES: The study sought to contrast risk profiles and compare outcomes of patients with severe aortic stenosis (AS) and coronary artery disease (CAD) who underwent aortic valve replacement (AVR) and coronary artery bypass grafting (AS+CABG) with those of patients with isolated AS who underwent AVR alone. BACKGROUND: In patients with severe AS, CAD is often an incidental finding with underappreciated survival implications. METHODS: From October 1991 to July 2010, 2,286 patients underwent AVR+CABG and 1,637 AVR alone. A propensity score was developed and used for matched comparisons of outcomes (1,082 patient pairs). Analyses of long-term mortality were performed for each group, then combined to identify common and unique risk factors. RESULTS: Patients with AS+CAD versus isolated AS were older, more symptomatic, and more likely to be hypertensive, and had lower ejection fraction and greater arteriosclerotic burden but less severe AS. Hospital morbidity and long-term survival were poorer (43% vs. 59% at 10 years). Both groups shared many mortality risk factors; however, early risk among AS+CAD patients reflected effects of CAD; late risk reflected diastolic left ventricular dysfunction expressed as ventricular hypertrophy and left atrial enlargement. Patients with isolated AS and few comorbidities had the best outcome, those with CAD without myocardial damage had intermediate outcome equivalent to propensity-matched isolated AS patients, and those with CAD, myocardial damage, and advanced comorbidities had the worst outcome. CONCLUSIONS: Cardiovascular risk factors and comorbidities must be considered in managing patients with severe AS. Patients with severe AS and CAD risk factors should undergo early diagnostics and AVR+CABG before ischemic myocardial damage occurs.
OBJECTIVES: The study sought to contrast risk profiles and compare outcomes of patients with severe aortic stenosis (AS) and coronary artery disease (CAD) who underwent aortic valve replacement (AVR) and coronary artery bypass grafting (AS+CABG) with those of patients with isolated AS who underwent AVR alone. BACKGROUND: In patients with severe AS, CAD is often an incidental finding with underappreciated survival implications. METHODS: From October 1991 to July 2010, 2,286 patients underwent AVR+CABG and 1,637 AVR alone. A propensity score was developed and used for matched comparisons of outcomes (1,082 patient pairs). Analyses of long-term mortality were performed for each group, then combined to identify common and unique risk factors. RESULTS:Patients with AS+CAD versus isolated AS were older, more symptomatic, and more likely to be hypertensive, and had lower ejection fraction and greater arteriosclerotic burden but less severe AS. Hospital morbidity and long-term survival were poorer (43% vs. 59% at 10 years). Both groups shared many mortality risk factors; however, early risk among AS+CADpatients reflected effects of CAD; late risk reflected diastolic left ventricular dysfunction expressed as ventricular hypertrophy and left atrial enlargement. Patients with isolated AS and few comorbidities had the best outcome, those with CAD without myocardial damage had intermediate outcome equivalent to propensity-matched isolated AS patients, and those with CAD, myocardial damage, and advanced comorbidities had the worst outcome. CONCLUSIONS: Cardiovascular risk factors and comorbidities must be considered in managing patients with severe AS. Patients with severe AS and CAD risk factors should undergo early diagnostics and AVR+CABG before ischemic myocardial damage occurs.
Authors: Yanto Sandy Tjang; Yvonne van Hees; Reiner Körfer; Diederick E Grobbee; Geert J M G van der Heijden Journal: Eur J Cardiothorac Surg Date: 2007-07-19 Impact factor: 4.191
Authors: Eric Lim; Ayyaz Ali; Panagiotis Theodorou; Ines Sousa; Hutan Ashrafian; Themis Chamageorgakis; Alison Duncan; Michael Henein; Peter Diggle; John Pepper Journal: Ann Thorac Surg Date: 2008-06 Impact factor: 4.330
Authors: Jocelyn M Beach; Tomislav Mihaljevic; Jeevanantham Rajeswaran; Thomas Marwick; Samuel T Edwards; Edward R Nowicki; James Thomas; Lars G Svensson; Brian Griffin; A Marc Gillinov; Eugene H Blackstone Journal: J Thorac Cardiovasc Surg Date: 2013-01-11 Impact factor: 5.209
Authors: Stefano De Castro; Stefano Caselli; Emanuele Di Angelantonio; Sara Del Colle; Francesca Mirabelli; Andrea Marcantonio; Danilo Puccio; Daria Santini; Natesa G Pandian Journal: Am J Cardiol Date: 2008-03-05 Impact factor: 2.778
Authors: Kimiyoshi J Kobayashi; Jason A Williams; Lois U Nwakanma; Eric S Weiss; Vincent L Gott; William A Baumgartner; John V Conte Journal: J Card Surg Date: 2009 Nov-Dec Impact factor: 1.620
Authors: Gudrun Lamm; Matthias Hammerer; Uta C Hoppe; Martin Andreas; Rudolf Berger; Ronald K Binder; Nikolaos Bonaros; Georg Delle-Karth; Matthias Frick; Michael Grund; Bernhard Metzler; Thomas Neunteufl; Philipp Pichler; Albrecht Schmidt; Wilfried Wisser; Andreas Zierer; Rainald Seitelberger; Michael Grimm; Alexander Geppert Journal: Wien Klin Wochenschr Date: 2021-03-23 Impact factor: 1.704
Authors: Tyler Calway; Daniel S Rubin; Heather E Moss; Charlotte E Joslin; Katharina Beckmann; Steven Roth Journal: Ophthalmology Date: 2016-11-30 Impact factor: 12.079
Authors: Giuseppe Di Gioia; Mariano Pellicano; Gabor G Toth; Filip Casselman; Julien Adjedj; Frank Van Praet; Bernard Stockman; Ivan Degrieck; Bruno Trimarco; William Wijns; Bernard De Bruyne; Emanuele Barbato Journal: J Cardiovasc Transl Res Date: 2016-02-16 Impact factor: 4.132
Authors: Iris Wilke; Jan Borosch; Simon Pecha; Sven Papmeyer; Stefan Behrens; Yskert von Kodolitsch; Ali Aydin Journal: Cardiovasc Diagn Ther Date: 2019-10